Can Kratom Cause a False Positive on a Drug Test?

Evidence-based answer reviewed against SAMHSA cutoffs and FDA assay documentation · Updated August 2026

Quick answer: Possibly — at the screening stage. Kratom does not cross-react with standard opiate screens in validated assays; older studies suggested weak methadone-assay interference, resolved by confirmatory testing. Confirmation testing (GC–MS/LC–MS/MS) distinguishes true positives from assay artifacts, so documented false positives almost never survive to final results.

How Kratom interacts with drug tests

Kratom is not on standard workplace panels. Its active alkaloids bind opioid receptors but are structurally unrelated to morphine, so opiate immunoassays do not react — a kratom user screens negative on a normal 5/10/12-panel cup.

Specialized liquid-chromatography testing can identify mitragynine and 7-hydroxymitragynine, but those tests are ordered mainly by pain clinics, researchers, or coroners, not HR departments.

Some 'legal high' warning systems now test for 7-OH specifically as concentrated extracts grow. If your program tests for novel psychoactive compounds, ask which expanded list applies.

State law matters: kratom is banned in a handful of states and municipalities regardless of testing practices.

The documented false-positive table

Source basis: Brahm NC et al., Mayo Clinic Proceedings 2008;83(1):66–76 plus FDA assay inserts. GC–MS/LC–MS confirmation eliminates these artifacts.
Screen flaggedDocumented cross-reactants (immunoassay tier only)
AmphetaminesBupropion (bupropion), trazodone, phentermine, pseudoephedrine, labetalol, promethazine, methylphenidate
PCPDextromethorphan (dextromethorphan cough syrup), diphenhydramine (diphenhydramine), doxylamine (multi-symptom cold remedies), tramadol, venlafaxine (venlafaxine), ketamine
OpiatesPoppy seeds (true positive), quinine, dextromethorphan, ofloxacin/levofloxacin, rifampin
BenzodiazepinesSertraline (sertraline), oxaprozin (case reports)
MethadoneDiphenhydramine, doxylamine, verapamil, quetiapine (quetiapine), clomipramine
Tricyclics (TCA)Cyclobenzaprine (cyclobenzaprine), hydroxyzine, carbamazepine, diphenhydramine
Cannabinoids (THC)Efavirenz, pantoprazole (isolated reports); dronabinol/dronabinol = true positive

How to defend a disputed result

  1. Declare everything at collection — prescriptions, sleep aids, poppy bagels. The collector's questionnaire feeds the MRO review.
  2. Answer the MRO call (three attempts over 24 hours in DOT programs). Missed calls convert positives automatically.
  3. Request split-specimen retest within 60 days if you dispute — the sealed second vial exists exactly for this.
  4. Bring documentation: pharmacy printouts, physician letters, discharge summaries.

Certified labs nationwide · Results in 1–2 days

Need a test? Order online, test same-day →
Medical disclaimer: DrugPanels provides educational information about laboratory drug testing and does not offer medical advice, diagnosis, or treatment. Detection windows are population ranges — individual results vary with metabolism, dose, frequency and health status. Never stop prescribed medication to pass a test without talking to your prescriber. Affiliate disclosure: some links on this page are affiliate links; if you order through them we may earn a commission at no additional cost to you.

People also ask

Does Kratom Show up on a Drug Test?

No — Kratom is absent from standard drug panels. Full guide →

Will Kratom Make You Fail a Drug Test?

Can Kratom trigger a false positive? Cross-reactivity evidence, confirmation testing, and how to clear your name with the MRO. Full guide →

How Long Can Kratom Be Detected in a Drug Test?

How long Kratom stays detectable in your system (all test types) — urine, hair, saliva & blood windows explained with cutoffs. Full guide →

How to Pass a Drug Test for Kratom?

Evidence-based ways to pass a drug test for Kratom — realistic timelines, what works, what backfires, and dilution flags to avoid. Full guide →

Do prescriptions count against me?

No — verified prescriptions report as negative through the Medical Review Officer. Declare medications at collection and answer the follow-up call.

Sources & further reading

  • SAMHSA — Mandatory Guidelines for Federal Workplace Drug Testing Programs (cutoffs, MRO process)
  • DOT — 49 CFR Part 40 procedures for transportation workplace testing
  • Brahm NC et al., Mayo Clinic Proceedings 2008;83(1):66–76 — false-positive cross-reactivity reference
  • FDA — drug-of-abuse test device labeling (detection window conventions)